全球功能性内视镜鼻窦手术市场

到 2030 年，全球功能性内视镜鼻窦手术市场规模将达到 18 亿美元

全球功能性内视镜鼻窦手术市场规模预计在2024年为12亿美元，预计到2030年将达到18亿美元，2024年至2030年的复合年增长率为5.9%。颚骨手术是本报告分析的细分市场之一，预计其复合年增长率为4.9%，到分析期结束时规模将达到11亿美元。筛窦手术细分市场在分析期间内的复合年增长率预计为7.7%。

美国市场规模估计为 3.39 亿美元，中国市场预计复合年增长率为 9.2%

美国功能性内视镜鼻窦手术市场规模预计在2024年达到3.39亿美元。作为世界第二大经济体，中国预计在2030年市场规模将达到3.537亿美元，在分析期间（2024-2030年）的复合年增长率为9.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为3.0%和5.8%。在欧洲，预计德国的复合年增长率为3.8%。

全球功能性内视镜鼻窦手术（FESS）市场－主要趋势与驱动因素摘要

为什么 FESS 成为治疗慢性鼻窦疾病的首选方法？

功能性内视镜鼻窦手术 (FESS) 已迅速成为治疗慢性鼻窦炎、鼻息肉和其他鼻窦疾病的标准治疗方法，其微创和高精度技术取代了传统的侵入性方法。 FESS 之所以受欢迎，是因为它能够在不损伤健康组织的情况下恢復鼻窦的正常通气和引流。使用高解析度内视镜和微型器械透过鼻孔进入鼻窦，可显着减少外部切口的需要，从而加快康復速度。耳鼻喉专家喜欢 FESS，因为术后併发症较少、住院时间较短、长期效果较好。全球慢性鼻窦炎盛行率的上升归因于污染、过敏、都市区生活方式和抗药性病菌感染，患者群体正在扩大。手术导引、即时成像和 3D 内视镜视觉化等技术进步使 FESS 比以往更安全、更精确。随着越来越多的患者寻求创伤更小、恢復更快的解决方案，并且付款人转向基于价值的护理，FESS 正在从一种专科选择演变为公立和私立医疗系统中耳鼻喉科广泛采用的手术标准。

工具和影像方面的创新如何提升手术精准度？

FESS 的发展与外科技术的进步密切相关，尤其是影像、导航和器械小型化。影像导引手术(IGS) 系统如今可透过术前 CT 或 MRI 扫描进行即时导航，大大降低了损伤邻近结构（例如眼眶或脑部）的风险。具有 4K 和 3D 视觉化功能的先进内视镜可提供无与伦比的清晰度和深度感知，从而提高外科医生在狭窄解剖路径中操作的能力。微切割器和射频探头等动力器械针对组织选择性切除进行了优化，从而能够以最小的创伤更可控地切除发炎或阻塞的组织。球囊扩张术通常被认为是 FESS 的补充或先导治疗方法，但在病情较轻的情况下，它已成为一种流行的检查室非侵入性治疗方法，可减轻手术室的负担。止血材料、生物可吸收支架和术后药物释放型植入等技术创新改善了术后癒合并降低了再次手术率。此外，人们正在探索利用机器人辅助技术，在解剖复杂和再次手术的病例中实施高精度手术。这些技术突破使FESS更加可预测、可重复，并使其在各种医院和门诊环境中更加便利。

哪些患者人口统计和临床趋势正在推动需求？

FESS 需求的成长很大程度上是由病患人口结构和临床照护模式的变化所驱动。慢性鼻窦炎影响着全球超过 10% 的人口，并且越来越多地被认定为一种对生活品质、工作效率和医疗保健成本有重大影响的疾病。中老年人的发生率最高，尤其是在都市区和工业地区，这些地区更容易受到空气污染和过敏原的影响。然而，随着安全性和復健状况的改善，越来越多的儿科和老年患者选择使用内视镜方法治疗。全球过敏性鼻炎、气喘以及爱滋病毒和糖尿病等免疫不全症的发生率上升也导致了鼻窦疾病盛行率的上升。有鼻窦手术史的患者更常选择修復手术，因为其成功率更高、併发症更少。从医疗服务提供者的角度来看，耳鼻喉诊所和门诊手术中心越来越多地提供 FESS，因为它具有收益潜力、患者偏好当日手术以及术前时间更短。随着 COVID 疫情后择期手术量的恢復，FESS 因其临床紧迫性和缓解症状的潜力，成为手术安排迅速恢復的手术之一。

功能性内视镜鼻窦手术市场的成长受到多种因素的推动

功能性内视镜鼻窦手术 (FESS) 市场的成长受到与临床进展、患者需求和医疗保健系统优先事项相关的多种因素的推动。首先，慢性鼻窦炎、鼻塞和过敏性息肉症的诊断率不断上升，导致手术族群不断扩大。其次，影像、导航和电动器械的技术进步正在提高手术成功率，同时最大限度地减少併发症。第三，对门诊病人和微创手术的推动，鼓励医疗机构优先考虑 FESS，而非传统方法。第四，优惠的报销政策和更低的医疗总成本，使 FESS 对医疗服务提供者和付款人更具吸引力。第五，全球关于鼻窦健康和未治疗感染疾病风险的宣传活动，鼓励患者儘早寻求专家咨询，从而提高手术转换率。最后，捆绑式手术套件、术后护理设备和鼻窦专用植入的出现，使耳鼻喉外科医生能够简化其 FESS 工作流程，使 FESS 不仅成为一种临床解决方案，而且成为现代耳鼻喉实践中一种高效的手术治疗方法。

部分

手术（上颚手术、筛窦手术）；适应症（慢性鼻窦炎适应症、鼻息肉适应症）；最终用途（医院最终用途、门诊手术中心最终用途、专科诊所最终用途）

受访公司范例（值得关注的32家公司）

• Acclarent, Inc.
• Adept Medical
• Advin Health Care
• Atmos MedizinTechnik GmbH & Co. KG
• B. Braun Melsungen AG
• Brainlab AG
• ClaroNav
• Collin Medical
• Conmed Corporation
• Ecleris
• Entermed
• Fiagon GmbH
• Grace Medical, Inc.
• Heal Force Bio-Meditech Holdings Ltd.
• Henke Sass Wolf GmbH
• Innovia Medical
• Integra LifeSciences
• Intersect ENT, Inc.
• Johnson & Johnson（Ethicon, Inc.）
• Karl Storz GmbH & Co. KG

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Functional Endoscopic Sinus Surgery Market to Reach US$1.8 Billion by 2030

The global market for Functional Endoscopic Sinus Surgery estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Maxillary Procedure, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Ethmoid Procedure segment is estimated at 7.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$339.0 Million While China is Forecast to Grow at 9.2% CAGR

The Functional Endoscopic Sinus Surgery market in the U.S. is estimated at US$339.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$353.7 Million by the year 2030 trailing a CAGR of 9.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global "Functional Endoscopic Sinus Surgery (FESS)" Market - Key Trends & Drivers Summarized

Why Is FESS Becoming the Preferred Approach for Chronic Sinus Conditions?

Functional Endoscopic Sinus Surgery (FESS) has rapidly gained prominence as the standard of care for treating chronic rhinosinusitis, nasal polyps, and other sinus pathologies, replacing traditional invasive methods with a minimally invasive, precision-based technique. The popularity of FESS stems from its ability to restore normal sinus ventilation and drainage without damaging healthy tissues. It employs high-definition endoscopes and micro-instruments to access sinus cavities through the nostrils, significantly reducing the need for external incisions and promoting faster recovery. ENT specialists prefer FESS due to reduced postoperative complications, shorter hospital stays, and better long-term outcomes. The rising incidence of chronic sinusitis globally-driven by pollution, allergies, urban lifestyles, and resistant bacterial infections-has expanded the patient base. Technological advances in surgical navigation, real-time imaging, and 3D endoscopic visualization have made FESS safer and more accurate than ever before. As more patients demand less invasive solutions with faster recovery times, and as payers lean toward value-based care, FESS is evolving from a specialist option to a widely adopted surgical norm in otolaryngology departments across both public and private healthcare systems.

How Are Innovations in Tools and Imaging Enhancing Surgical Precision?

The evolution of FESS is deeply tied to the progress of surgical technology, particularly in imaging, navigation, and instrument miniaturization. Image-guided surgery (IGS) systems now allow real-time navigation using preoperative CT or MRI scans, significantly reducing the risk of damaging adjacent structures such as the orbit or brain. Advanced endoscopes with 4K and 3D visualization offer unparalleled clarity and depth perception, enhancing surgeons’ ability to maneuver in narrow anatomical pathways. Powered instruments like microdebriders and radiofrequency probes are being optimized for tissue-selective resection, allowing more controlled removal of inflamed or obstructive tissue with minimal trauma. Balloon sinuplasty-often considered a complement or precursor to FESS-is also gaining traction for milder cases, offering office-based, non-invasive alternatives that reduce the burden on operating rooms. Innovations in hemostatic materials, bioabsorbable stents, and post-op drug-eluting implants are improving postoperative healing and reducing revision rates. Additionally, robotic assistance is being explored for high-precision procedures in anatomically complex or revision cases. These technological breakthroughs are making FESS more predictable, reproducible, and accessible across a range of hospital and ambulatory care settings.

Which Patient Demographics and Clinical Trends Are Driving Demand?

The growing demand for FESS is largely influenced by shifting patient demographics and clinical care models. Chronic sinusitis affects over 10% of the global population and is increasingly recognized as a condition that significantly impacts quality of life, work productivity, and healthcare costs. The highest incidence is seen in middle-aged adults, particularly in urban and industrial regions with high air pollution and allergen exposure. However, there’s a growing trend of pediatric and geriatric patients being treated via endoscopic methods as safety and recovery profiles improve. The global rise in allergic rhinitis, asthma, and immunocompromised conditions such as HIV and diabetes has also contributed to increased sinus disease prevalence. Patients with prior sinus surgeries are now more frequently opting for revision FESS due to better success rates and low complication profiles. From a provider standpoint, ENT clinics and outpatient surgical centers are increasingly offering FESS due to its revenue-generating potential, patient preference for day surgeries, and shorter preoperative timelines. As elective surgery volumes recover post-COVID, FESS is among the procedures seeing rapid scheduling rebounds due to its clinical urgency and symptom relief potential.

The Growth in the Functional Endoscopic Sinus Surgery Market Is Driven by Several Factors

The growth in the functional endoscopic sinus surgery (FESS) market is driven by several factors related to clinical advancements, patient demand, and health system priorities. First, increased diagnosis of chronic rhinosinusitis, nasal obstructions, and allergic polyposis is expanding the eligible surgical population. Second, technological progress in imaging, navigation, and powered instrumentation is enhancing procedure success rates while minimizing complications. Third, the push for outpatient and minimally invasive procedures is encouraging healthcare facilities to prioritize FESS over conventional approaches. Fourth, favorable reimbursement policies and reduced total cost of care are making it more appealing to providers and payers alike. Fifth, global awareness campaigns around sinus health and the risks of untreated infections are pushing patients to seek specialist consultations earlier, increasing procedural conversion rates. Finally, the emergence of bundled surgical kits, post-op care devices, and sinus-specific implantables is enabling ENT surgeons to streamline FESS workflows-making it not just a clinical solution, but also an operationally efficient offering within modern otolaryngology.

SCOPE OF STUDY:

The report analyzes the Functional Endoscopic Sinus Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Procedure (Maxillary Procedure, Ethmoid Procedure); Indication (Chronic Sinusitis Indication, Nasal Polyposis Indication); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Acclarent, Inc.
• Adept Medical
• Advin Health Care
• Atmos MedizinTechnik GmbH & Co. KG
• B. Braun Melsungen AG
• Brainlab AG
• ClaroNav
• Collin Medical
• Conmed Corporation
• Ecleris
• Entermed
• Fiagon GmbH
• Grace Medical, Inc.
• Heal Force Bio-Meditech Holdings Ltd.
• Henke Sass Wolf GmbH
• Innovia Medical
• Integra LifeSciences
• Intersect ENT, Inc.
• Johnson & Johnson (Ethicon, Inc.)
• Karl Storz GmbH & Co. KG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Functional Endoscopic Sinus Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Sinusitis Drives Demand for Advanced FESS Procedures
  • Technological Innovations in Endoscopic Instruments Propel Adoption of Minimally Invasive Techniques
  • Growth in Ambulatory Surgical Centers Expands Accessibility of Functional Sinus Surgeries
  • Improved Patient Outcomes and Reduced Recovery Times Strengthen Business Case for FESS
  • Increasing ENT Specialist Adoption of Image-Guided Navigation Systems Enhances Procedural Precision
  • Healthcare Reimbursement Reforms Accelerate Uptake of Functional Sinus Interventions
  • Advancements in Balloon Sinuplasty and 3D Visualization Tools Expand Market Penetration
  • Focus on Patient-Centric Care Models Throws Spotlight on Daycare Endoscopic Procedures
  • Rising Awareness of Allergic Rhinitis and Nasal Disorders Sustains Procedural Demand
  • Training and Certification Programs Enhance Surgeon Readiness and Broaden FESS Adoption
  • Integration of AI and Robotics in ENT Surgeries Spurs Innovation in FESS Market
  • Global Medical Tourism Trends Generate Cross-Border Demand for Cost-Effective FESS Solutions
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Functional Endoscopic Sinus Surgery Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Maxillary Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Maxillary Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Maxillary Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ethmoid Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Ethmoid Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Ethmoid Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Chronic Sinusitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Chronic Sinusitis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Chronic Sinusitis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Nasal Polyposis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Nasal Polyposis Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Nasal Polyposis Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: Canada 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 47: Japan Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Japan Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Japan 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Japan 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 53: China Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: China Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: China 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 56: China Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: China Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: China 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 59: China Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: China 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 62: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: Europe Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 65: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Europe Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 74: France Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: France Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: France 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 77: France Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: France 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: France 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Germany 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Germany 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Germany 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Italy 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 95: Italy Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Italy Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Italy 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Italy 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 101: UK Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: UK Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: UK 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 104: UK Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UK Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: UK 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 107: UK Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: UK 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 110: Spain Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Spain Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Spain 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 113: Spain Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Spain Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: Spain 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Spain 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 119: Russia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Russia Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Russia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 122: Russia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Russia Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Russia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Russia 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Europe Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Europe Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 138: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 149: Australia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Australia Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Australia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 152: Australia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Australia Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Australia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Australia 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 158: India Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: India Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: India 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 161: India Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: India Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: India 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 164: India Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: India 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 167: South Korea Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: South Korea Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: South Korea 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 170: South Korea Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: South Korea Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: South Korea 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: South Korea 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 185: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 186: Latin America Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 188: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Latin America Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 197: Argentina Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Argentina Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Argentina 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 200: Argentina Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Argentina Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Argentina 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Argentina 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 206: Brazil Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Brazil Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Brazil 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 209: Brazil Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Brazil Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Brazil 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Brazil 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 215: Mexico Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Mexico Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Mexico 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 218: Mexico Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Mexico Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Mexico 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Mexico 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Rest of Latin America Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Rest of Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Rest of Latin America Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Rest of Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 233: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 234: Middle East Historic Review for Functional Endoscopic Sinus Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 236: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Middle East Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 245: Iran Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Iran Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Iran 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 248: Iran Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Iran Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Iran 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Iran 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 254: Israel Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Israel Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Israel 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 257: Israel Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Israel Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Israel 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Israel 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Saudi Arabia Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Saudi Arabia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Saudi Arabia Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Saudi Arabia 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 272: UAE Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: UAE Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: UAE 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 275: UAE Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: UAE Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: UAE 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: UAE 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Rest of Middle East Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Rest of Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Rest of Middle East Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Rest of Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Functional Endoscopic Sinus Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 290: Africa Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Africa Historic Review for Functional Endoscopic Sinus Surgery by Procedure - Maxillary Procedure and Ethmoid Procedure Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Africa 16-Year Perspective for Functional Endoscopic Sinus Surgery by Procedure - Percentage Breakdown of Value Sales for Maxillary Procedure and Ethmoid Procedure for the Years 2014, 2025 & 2030
  • TABLE 293: Africa Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Africa Historic Review for Functional Endoscopic Sinus Surgery by Indication - Chronic Sinusitis Indication and Nasal Polyposis Indication Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Africa 16-Year Perspective for Functional Endoscopic Sinus Surgery by Indication - Percentage Breakdown of Value Sales for Chronic Sinusitis Indication and Nasal Polyposis Indication for the Years 2014, 2025 & 2030
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Functional Endoscopic Sinus Surgery by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Africa 16-Year Perspective for Functional Endoscopic Sinus Surgery by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION